Physician profile
John L Pontolillo
NPI 1790170926
$5,222.70
in general payments reported to CMS, 2019-2025
14 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,211 · 2020: $645 · 2021: $1,617 · 2023: $79.85 · 2024: $384 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650 · Gift: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.04 |
| Gift | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,562.80 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $740.99 | 2019-2021 | |
| Medtronic Vascular, INC. | $614.39 | 2019 | |
| W. L. Gore & Associates, INC. | $603.85 | 2021-2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
| Medtronic, INC. | $513.24 | 2021 | |
| Sirtex Medical INC | $427.34 | 2023-2025 | Sir-Spheres Microspheres |
| Biocompatibles, INC. | $261.95 | 2019 | |
| Cardiovascular Systems INC. | $125.88 | 2020 | |
| Medtronic USA, INC. | $107.29 | 2019 | |
| Agfa Healthcare Corporation | $100.00 | 2024 | |
| Penumbra, INC. | $70.30 | 2025 | Indigo System |
| Trisalus Life Sciences, INC. | $59.77 | 2025 | Trinav Infusion System |
| Abbott Laboratories | $21.06 | 2021 | |
| Covidien LP | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pontolillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.